Sign In | Join Free | My vivirlatino.com
vivirlatino.com
HONGKONG YUANCHENG GONGCHUANG TECHNOLOGY Co., LIMITED
Your most reliable Steroid Supplier!! Factory direct sales, Great quality and purity, and 100% sure for reshiping!!!
Home > Oral Anabolic Steroids >

Rimonabant Oral Anabolic Steroids Anorectic Antiobesity Drug CAS 168273-06-1

HONGKONG YUANCHENG GONGCHUANG TECHNOLOGY Co., LIMITED
Trust Seal
Verified Supplier
Credit Check
Supplier Assessment

Rimonabant Oral Anabolic Steroids Anorectic Antiobesity Drug CAS 168273-06-1

Brand Name : ChineseHormone
Model Number : CAS 168273-06-1
Certification : GMP, ISO 9001, USP
Place of Origin : China
MOQ : Free samples Available
Price : negotiated
Payment Terms : Western Union, MoneyGram, T/T, Bitcoin
Supply Ability : 500-1000 kg / month
Delivery Time : 3-7 working days
Packaging Details : as your required
MW : 463.787
MF : C22H21Cl3N4O
Appearance : White crystalline powder
Water Solubility : 0.002 mg/mL
Alias : SR141716, Acomplia, Zimulti
Shipment : FedEx, TNT, EMS, DHL.UPS,EUB
Contact Now

Rimonabant Oral Anabolic Steroids Anorectic Antiobesity Drug CAS 168273-06-1


CAS number168273-06-1

WeightAverage: 463.787
Monoisotopic: 462.078094435

Chemical Formula :C22H21Cl3N4O


Rimonabant (also known as SR141716; trade names Acomplia, Zimulti) is an anorectic antiobesity drug that has been withdrawn from the market due to potentially serious side effects. It was approved for use in Europe and other countries, but never approved in the United States. Rimonabant is an inverse agonist for the cannabinoid receptor CB1. It has also been shown to be a μ-opioid receptor antagonist(possibly the contributing factor in its reported dysphoric qualities). Its main effect is reduction in appetite.


Uses/potential uses


Obesity


In a 2006 (2 year) study reported in JAMA, "Compared with the placebo group, the 20 mg of rimonabant group produced greater mean (SEM) reductions in weight (-6.3 [0.2] kg vs -1.6 [0.2] kg; P<.001), waist circumference (-6.1 [0.2] cm vs -2.5 [0.3] cm; P<.001), and level of triglycerides (percentage change, -5.3 [1.2] vs 7.9 [2.0]; P<.001) and a greater increase in level of high-density lipoprotein cholesterol (percentage change, 12.6 [0.5] vs 5.4 [0.7]; P<.001)."


Smoking cessation


Rimonabant may also be found to be effective in assisting some smokers to quit smoking. Sanofi is currently conducting studies to determine the possible value of rimonabant in smoking-cessation therapy. The Studies with Rimonabant and Tobacco Use (STRATUS) program involves more than 6,000 subjects. STRATUS is designed to explore two smoking-related therapies: first, to use rimonabant directly to aid in smoking cessation; second, to help prevent weight gain in former smokers.


Initial results apparently suggest rimonabant is effective for both uses. However, the FDA has explicitly stated to Sanofi that, without additional studies, rimonabant cannot be approved in the United States for smoking cessation therapy. According to a Cochrane Collaboration review in 2007, rimonabant "may increase the odds of quitting approximately 11/2-fold".


Addiction behaviors


Rimonabant reduced resumption of cocaine-seeking responses triggered by two of the three most common triggers of relapse in humans: priming and cues. It may also reduce ethanol and opiate-seeking behavior.


Short-term memory


Tetrahydrocannabinol (THC) is known to impair short-term memory. It was therefore hypothesised that rimonabant may reduce or inhibit the atrophic effects of cannabinoids. Indeed, in animal studies, it significantly improved the ability of rats to encode information into short-term memory.


Blockage of cannabis effects


Rimonabant blocks the psychoactive and some of the cardiovascular effects of Δ9-tetrahydrocannabinol (THC) in humans without affecting the pharmacokinetics. Rimonabant has been described colloquially as "reverse marijuana", having a depressing effect on appetite inverse to the increased appetite created by cannabinoids.


Predicted Properties


PropertyValueSource
Water Solubility0.002 mg/mLALOGPS
logP5.47ALOGPS
logP5.91ChemAxon
logS-5.4ALOGPS
pKa (Strongest Acidic)12.42ChemAxon
pKa (Strongest Basic)1.68ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area50.16 Å2ChemAxon
Rotatable Bond Count4ChemAxon
Refractivity122.83 m3·mol-1ChemAxon
Polarizability47.96 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleYesChemAxon



Product Tags:

Legal Oral Steroids

      

Safe Muscle Building Steroids

      
China Customized Inflatable Bumper Ball Game Bubble Adult Grass CE supplier

Rimonabant Oral Anabolic Steroids Anorectic Antiobesity Drug CAS 168273-06-1 Images

Inquiry Cart 0
Send your message to this supplier
 
From:
Enter your email please.
To: HONGKONG YUANCHENG GONGCHUANG TECHNOLOGY Co., LIMITED
Subject:
Message:
Characters Remaining: (0/3000)
 
Inquiry Cart 0